- Research Grants
Rebeca Piatniczka Iglesia in research grants and scholarships supported by FAPESP.
Glioblastoma multiforme (GBM), the most aggressive type of brain tumor, is initiated and maintained by a subpopulation of tumorigenic cells called glioblastoma stem cells (GSCs) that contribute to progression and resistance to therapy. In GBM therapy the alkylating agent temozolomide (TMZ) is the most effective chemotherapist, but resistance is frequent. One of the mechanisms of resista...
Glioblastomas (GBM) are highly lethal brain tumors, which contains a subpopulation of Glioblastoma Stem Cells (GSC) capable of promoting tumor angiogenesis, invasion and radiotherapy and chemotherapy resistance, contributing to the failure to treat these cancers. Studies show that the interaction of two proteins, the cellular prion protein (PrPC) and stress inducible protein 1 (STI1), p...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|
(References retrieved automatically from State of São Paulo Research Institutions)
IGLESIA, Rebeca Piatniczka. Estudo da interação entre PrPC e STI1/HOP na biologia de células-tronco de glioblastoma humano in vivo.. 2017. Tese (Doutorado) – Instituto de Ciências Biomédicas. Universidade de São Paulo (USP). São Paulo.